Mutations in Pten are frequently found both in sporadic and hereditary cancers, and mice with Pten deletion and/or loss-of-function mutations are highly susceptible to tumor induction by aberrant phosphatidylinositol 3-kinase (PI3K)/Akt pathway activation [1, 2]. This evidence concerns the gene PTEN and neoplasm.